Literature DB >> 14515206

Corepressor SMRT specifically represses the transcriptional activity of orphan nuclear receptor hB1F/hLRH-1.

Ping-Long Xu1, Yu-Ying Kong, You-Hua Xie, Yuan Wang.   

Abstract

The orphan nuclear receptor hB1F (also known as NR5A2, LRH-1, FTF or CPF) plays important roles in regulating the expression of several cellular and viral genes actively involved in a wide range of biological processes such as the bile acid biosynthesis, liver specific gene regulatory network and hepatitis B virus replication. The activity of nuclear receptors is regulated by multiple mechanisms, including coactivation and corepression. In this study, it was found that the silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT) specifically represses the transcriptional activity of hB1F, on either GAL4 dependent reporter system or the hB1F-responsive HBV enhancer II/core promoter. The repression imposed by SMRT is observed in different cell lines. Interestingly, hB1F couldn t interact with SMRT directly, as demonstrated by mammalian two-hybrid analysis or GST pull-down assay. Taken together, it can be concluded for the first time that the transcriptional activity of hB1F is regulated specifically by the corepressor SMRT via an indirect mechanism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14515206

Source DB:  PubMed          Journal:  Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)        ISSN: 0582-9879


  6 in total

1.  Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation.

Authors:  Paul M Musille; Manish Pathak; Janelle L Lauer; William H Hudson; Patrick R Griffin; Eric A Ortlund
Journal:  Nat Struct Mol Biol       Date:  2012-04-15       Impact factor: 15.369

Review 2.  Emerging actions of the nuclear receptor LRH-1 in the gut.

Authors:  Pablo J Fernandez-Marcos; Johan Auwerx; Kristina Schoonjans
Journal:  Biochim Biophys Acta       Date:  2010-12-29

Review 3.  Hepatic glucose sensing and integrative pathways in the liver.

Authors:  Maaike H Oosterveer; Kristina Schoonjans
Journal:  Cell Mol Life Sci       Date:  2013-11-07       Impact factor: 9.261

Review 4.  Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer.

Authors:  Christina Nadolny; Xiaoqun Dong
Journal:  Cancer Biol Ther       Date:  2015-05-07       Impact factor: 4.742

5.  Divergent sequence tunes ligand sensitivity in phospholipid-regulated hormone receptors.

Authors:  Paul M Musille; Manish Pathak; Janelle L Lauer; Patrick R Griffin; Eric A Ortlund
Journal:  J Biol Chem       Date:  2013-06-04       Impact factor: 5.157

6.  LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner.

Authors:  Holly B Kramer; Chun-Fui Lai; Hetal Patel; Manikandan Periyasamy; Meng-Lay Lin; Stephan M Feller; Frances V Fuller-Pace; David W Meek; Simak Ali; Laki Buluwela
Journal:  Nucleic Acids Res       Date:  2015-09-22       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.